Insecticides India Share Price
Sector: Chemical Manufacturing
957.30 -2.50 (-0.26%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
953.20
Today’s High
974.35
52 Week Low
531.60
52 Week High
1084.65
961.60 +1.15 (0.12%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
954.05
Today’s High
974.90
52 Week Low
542.55
52 Week High
1084.25
Key Metrics
- Market Cap (In Cr) 2785.54
- Beta 0.53
- Div. Yield (%) 0.21
- P/B 2.58
- TTM P/E 12.29
- Sector P/E 17.63
- D/E 0
- Open Price 955.65
- Prev Close 959.8
Insecticides India Analysis
Price Analysis
-
1 Week5.64%
-
3 Months62.55%
-
6 Month37%
-
YTD42.65%
-
1 Year41.05%
Risk Meter
- 39% Low risk
- 39% Moderate risk
- 39% Balanced Risk
- 39% High risk
- 39% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Insecticides India News
Q4 results today: IRCTC, Deepak Nitrate, SAIL, Cummins, Bata India on May 28
2 min read . 28 May 2025Godrej Consumer Products bullish on demand revival amid easing inflation
3 min read . 07 May 2025This agrochemical multibagger stock touches record high post robust Q1 results
2 min read . 12 Aug 2024Insecticides India Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1999.95
- Selling/ General/ Admin Expenses Total
- 138.71
- Depreciation/ Amortization
- 29.15
- Other Operating Expenses Total
- 280.9
- Total Operating Expense
- 1807.89
- Operating Income
- 192.06
- Net Income Before Taxes
- 192.77
- Net Income
- 142.02
- Diluted Normalized EPS
- 48.38
- Period
- 2025
- Total Assets
- 1898.15
- Total Liabilities
- 813.55
- Total Equity
- 1084.59
- Tangible Book Valueper Share Common Eq
- 368.06
- Period
- 2025
- Cashfrom Operating Activities
- 93.46
- Cashfrom Investing Activities
- -37.72
- Cashfrom Financing Activities
- -61.09
- Net Changein Cash
- -5.36
- Period
- 2024
- Total Revenue
- 1966.39
- Selling/ General/ Admin Expenses Total
- 117.45
- Depreciation/ Amortization
- 29.25
- Other Operating Expenses Total
- 221.59
- Total Operating Expense
- 1833.32
- Operating Income
- 133.07
- Net Income Before Taxes
- 131.89
- Net Income
- 102.07
- Diluted Normalized EPS
- 34.49
- Period
- 2024
- Total Assets
- 1719.22
- Total Liabilities
- 707.5
- Total Equity
- 1011.72
- Tangible Book Valueper Share Common Eq
- 337.24
- Period
- 2024
- Cashfrom Operating Activities
- 186.98
- Cashfrom Investing Activities
- -46.47
- Cashfrom Financing Activities
- -98.06
- Net Changein Cash
- 42.45
- Period
- 2023
- Total Revenue
- 1801.33
- Selling/ General/ Admin Expenses Total
- 231.84
- Depreciation/ Amortization
- 26.1
- Other Operating Expenses Total
- 4.61
- Total Operating Expense
- 1705.61
- Operating Income
- 95.72
- Net Income Before Taxes
- 83.83
- Net Income
- 63.21
- Diluted Normalized EPS
- 21.41
- Period
- 2023
- Total Assets
- 1696.31
- Total Liabilities
- 778.02
- Total Equity
- 918.29
- Tangible Book Valueper Share Common Eq
- 306.01
- Period
- 2023
- Cashfrom Operating Activities
- -10.63
- Cashfrom Investing Activities
- -86.4
- Cashfrom Financing Activities
- 79.68
- Net Changein Cash
- -17.35
- Period
- 2022
- Total Revenue
- 1503.96
- Selling/ General/ Admin Expenses Total
- 169.39
- Depreciation/ Amortization
- 26.35
- Other Operating Expenses Total
- 6.48
- Total Operating Expense
- 1359.39
- Operating Income
- 144.57
- Net Income Before Taxes
- 141.37
- Net Income
- 107.43
- Diluted Normalized EPS
- 36.46
- Period
- 2022
- Total Assets
- 1396.2
- Total Liabilities
- 526.59
- Total Equity
- 869.61
- Tangible Book Valueper Share Common Eq
- 289.97
- Period
- 2022
- Cashfrom Operating Activities
- 134.85
- Cashfrom Investing Activities
- 9.31
- Cashfrom Financing Activities
- -114.64
- Net Changein Cash
- 29.52
- Period
- 2021
- Total Revenue
- 1420.23
- Selling/ General/ Admin Expenses Total
- 151.39
- Depreciation/ Amortization
- 24.67
- Other Operating Expenses Total
- 10.3
- Total Operating Expense
- 1301.89
- Operating Income
- 118.34
- Net Income Before Taxes
- 119.5
- Net Income
- 93.9
- Diluted Normalized EPS
- 32.84
- Period
- 2021
- Total Assets
- 1425.95
- Total Liabilities
- 605.57
- Total Equity
- 820.38
- Tangible Book Valueper Share Common Eq
- 261.01
- Period
- 2021
- Cashfrom Operating Activities
- 155.36
- Cashfrom Investing Activities
- -112.6
- Cashfrom Financing Activities
- -104.03
- Net Changein Cash
- -61.27
- Period
- 2020
- Total Revenue
- 1363.22
- Selling/ General/ Admin Expenses Total
- 143.32
- Depreciation/ Amortization
- 24.07
- Other Operating Expenses Total
- 7.72
- Total Operating Expense
- 1226.13
- Operating Income
- 137.09
- Net Income Before Taxes
- 111.33
- Net Income
- 86.91
- Diluted Normalized EPS
- 28.13
- Period
- 2020
- Total Assets
- 1294.42
- Total Liabilities
- 562.69
- Total Equity
- 731.73
- Tangible Book Valueper Share Common Eq
- 232.45
- Period
- 2020
- Cashfrom Operating Activities
- 241.85
- Cashfrom Investing Activities
- -24.09
- Cashfrom Financing Activities
- -158.98
- Net Changein Cash
- 58.79
- Period
- 2019
- Total Revenue
- 1191.95
- Selling/ General/ Admin Expenses Total
- 140.18
- Depreciation/ Amortization
- 19.68
- Other Operating Expenses Total
- 5.02
- Total Operating Expense
- 1020.3
- Operating Income
- 171.65
- Net Income Before Taxes
- 153.41
- Net Income
- 122.81
- Diluted Normalized EPS
- 39.74
- Period
- 2019
- Total Assets
- 1355.55
- Total Liabilities
- 693.54
- Total Equity
- 662
- Tangible Book Valueper Share Common Eq
- 210.53
- Period
- 2019
- Cashfrom Operating Activities
- -133.13
- Cashfrom Investing Activities
- -48.99
- Cashfrom Financing Activities
- 171.5
- Net Changein Cash
- -10.62
- Period
- 2025-03-31
- Total Revenue
- 358.92
- Selling/ General/ Admin Expenses Total
- 28.63
- Depreciation/ Amortization
- 7.17
- Other Operating Expenses Total
- 74.25
- Total Operating Expense
- 337.62
- Operating Income
- 21.3
- Net Income Before Taxes
- 22.02
- Net Income
- 13.89
- Diluted Normalized EPS
- 4.77
- Period
- 2025-03-31
- Total Assets
- 1898.15
- Total Liabilities
- 813.55
- Total Equity
- 1084.59
- Tangible Book Valueper Share Common Eq
- 368.06
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 93.46
- Cashfrom Investing Activities
- -37.72
- Cashfrom Financing Activities
- -61.09
- Net Changein Cash
- -5.36
- Period
- 2024-12-31
- Total Revenue
- 357.7
- Selling/ General/ Admin Expenses Total
- 32.49
- Depreciation/ Amortization
- 7.58
- Other Operating Expenses Total
- 65.8
- Total Operating Expense
- 334.39
- Operating Income
- 23.31
- Net Income Before Taxes
- 22.28
- Net Income
- 17.37
- Diluted Normalized EPS
- 5.96
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 627.09
- Selling/ General/ Admin Expenses Total
- 38.46
- Depreciation/ Amortization
- 7.25
- Other Operating Expenses Total
- 70.44
- Total Operating Expense
- 544.78
- Operating Income
- 82.32
- Net Income Before Taxes
- 82.32
- Net Income
- 61.49
- Diluted Normalized EPS
- 20.78
- Period
- 2024-09-30
- Total Assets
- 1811.5
- Total Liabilities
- 693.24
- Total Equity
- 1118.26
- Tangible Book Valueper Share Common Eq
- 373.16
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 58.3
- Cashfrom Investing Activities
- -17.79
- Cashfrom Financing Activities
- -32.6
- Net Changein Cash
- 7.9
- Period
- 2024-06-30
- Total Revenue
- 656.69
- Selling/ General/ Admin Expenses Total
- 38.85
- Depreciation/ Amortization
- 7.13
- Other Operating Expenses Total
- 70.24
- Total Operating Expense
- 592.32
- Operating Income
- 64.37
- Net Income Before Taxes
- 65.43
- Net Income
- 49.01
- Diluted Normalized EPS
- 16.56
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 272.5
- Selling/ General/ Admin Expenses Total
- 25.92
- Depreciation/ Amortization
- 7.6
- Other Operating Expenses Total
- 52.19
- Total Operating Expense
- 271.37
- Operating Income
- 1.13
- Net Income Before Taxes
- 3.51
- Net Income
- 7.52
- Diluted Normalized EPS
- 2.54
- Period
- 2024-03-31
- Total Assets
- 1719.22
- Total Liabilities
- 707.5
- Total Equity
- 1011.72
- Tangible Book Valueper Share Common Eq
- 337.24
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 186.98
- Cashfrom Investing Activities
- -46.47
- Cashfrom Financing Activities
- -98.06
- Net Changein Cash
- 42.45
- Period
- 2023-12-31
- Total Revenue
- 357.94
- Selling/ General/ Admin Expenses Total
- 27.75
- Depreciation/ Amortization
- 7.42
- Other Operating Expenses Total
- 54.2
- Total Operating Expense
- 339.35
- Operating Income
- 18.59
- Net Income Before Taxes
- 17.03
- Net Income
- 12.26
- Diluted Normalized EPS
- 4.14
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Insecticides India Technical
Moving Average
SMA
- 5 Day949.18
- 10 Day925.59
- 20 Day888.85
- 50 Day792.06
- 100 Day695.97
- 300 Day737.04
Insecticides India Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Savita Oil Technologies
- 422.6
- 4.45
- 1.06
- 655
- 295
- 2902.57
- Iol Chemicals And Pharmaceu
- 97.5
- 2.63
- 2.77
- 107.41
- 57.51
- 2861.9
- Insecticides India
- 957.3
- -2.5
- -0.26
- 1084.65
- 531.6
- 2785.54
- India Pesticides
- 220.7
- -0.25
- -0.11
- 236.4
- 119.85
- 2541.66
- Yasho Industries
- 2051
- 13.45
- 0.66
- 2330
- 1601
- 2451.91
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Savita Oil Technologies
- 25.69
- 1.74
- 15.32
- 6.39
- Iol Chemicals And Pharmaceu
- 28.34
- 1.7
- 14.05
- 9.33
- Insecticides India
- 19.85
- 2.58
- 11.23
- 5.85
- India Pesticides
- 31
- 2.84
- -
- -
- Yasho Industries
- 388.52
- 5.94
- 20.1
- 7.08
Insecticides India Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results & Others
- 10-Feb-25
- Quarterly Results & Others
- 11-Nov-24
- Quarterly Results
- 30-Aug-24
- Buy Back of Shares
- 09-Aug-24
- Quarterly Results
- 28-May-24
- Audited Results
- 05-Feb-24
- Quarterly Results
- 02-Nov-23
- Quarterly Results & Interim Dividend
- 10-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 12-Aug-24
- 18-Jul-24
- AGM
- 23-Sept-23
- 10-Aug-23
- AGM
- 09-Sept-21
- 22-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 24-Jul-24
- 23-Aug-24
- 23-Aug-24
- 2
- 29-Sept-23
- 10-Nov-23
- 10-Nov-23
- 3
- 03-Feb-23
- 24-Feb-23
- 24-Feb-23
- 3
- 26-May-22
- -
- 15-Sept-22
- 3
- Announced on
- Record Date
- Ex-Bonus
- Description
- 20-Aug-22
- 03-Oct-22
- 30-Sept-22
- Bonus issue in the ratio of 1:2 of Rs. 10/-.

